{"id":207526,"name":"IOVANCE BIOTHERAPEUTICS, INC.","slug":"iovance-biotherapeutics-inc","state":"CA","country":"United States of America","description":"Development and commercialization of immunotherapies","totalSpending":420000,"filings":12,"yearlySpending":[{"year":2020,"income":30000},{"year":2021,"income":190000},{"year":2022,"income":200000},{"year":2023,"income":0}],"issues":[{"code":"MMM","display":"Medicare/Medicaid"}],"firms":["AVENUE SOLUTIONS"],"lobbyists":["TRACY SPICER","ELIZABETH BARNETT"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["Education around tumor infiltrating lymphocytes (TIL) cancer therapies","Education around tumor infiltrating lymphocytes (TIL) cancer therapies;\n\nH.R. 133, Consolidated Appropriations Act, 2021 (Public Law 116-260)","Education around tumor infiltrating lymphocytes (TIL) cancer therapies;\n\nH.R. 1319, American Rescue Plan Act of 2021 (PL 117-2); \n\nContinued monitoring of Consolidated Appropriations Act, 2021 (PL 116","Education around tumor infiltrating lymphocytes (TIL) cancer therapies;\n\nImplementation of American Rescue Plan Act of 2021 (PL 117-2); \n\nContinued monitoring of Consolidated Appropriations Act, 2021 ","Education around tumor infiltrating lymphocytes (TIL) cancer therapies;\n\nImplementation of American Rescue Plan Act of 2021 (PL 117-2); \n\nContinued monitoring of Consolidated Appropriations Act, 2021 "]}